Skip to main content
Top
Published in: Rheumatology International 11/2010

01-09-2010 | Original Article

Clinical and radiological features of Takayasu’s arteritis patients in Jordan

Authors: Khader N. Mustafa, Azmy Hadidy, Nadera J. Sweiss

Published in: Rheumatology International | Issue 11/2010

Login to get access

Abstract

The prevalence of Takayasu’s arteritis (TA) varies greatly among world populations, and little is known about this disease in Eastern Mediterranean Arab populations. We conducted a retrospective chart review of patients diagnosed with TA from 1996 to 2008 at a single large referral center in Jordan. Eight patients (seven females, one male) with angiographically diagnosed TA were seen at the Jordan University Hospital between 1996 and 2008. All patients were of Arabic ethnicity. The age at presentation ranged from 14 to 50 years, and delay in diagnosis ranged from 1 to 10 years. Extra-vascular manifestations included nodular episcleritis, elevated liver enzymes, erythema nodosum, inflammatory-bowel-disease-like illness, Raynaud’s phenomena, and constitutional symptoms. Vascular symptoms included postural dizziness, central nervous system deficits, amauroses fugax, and transient ischemic attacks. Aortic arch vessels were involved in all patients, the abdominal aorta was involved in five patients, and the renal arteries in four patients. Major clinical events including severe stroke and cardiac failure were associated with mortality in two patients. Treatment with corticosteroids and immunosuppressive agents resulted in improvement in five patients with follow-up ranging from 3 to 12 years. In conclusion, TA is seen in Arabs, and the clinical spectrum of TA in Arabs in Jordan is similar to that reported in other countries. Increased awareness of the disease may shorten the time to diagnosis and result in a more reliable estimate of disease prevalence.
Literature
1.
go back to reference Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y et al (2008) Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 118:2738–2747CrossRefPubMed Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y et al (2008) Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 118:2738–2747CrossRefPubMed
2.
go back to reference Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefPubMed Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefPubMed
3.
go back to reference Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (1977) Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 93:94–103CrossRefPubMed Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (1977) Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 93:94–103CrossRefPubMed
4.
5.
go back to reference Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG (1985) Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 64:89–99 Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG (1985) Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 64:89–99
6.
go back to reference el-Reshaid K, Varro J, al-Duwairi Q, Anim JT (1995) Takayasu’s arteritis in Kuwait. J Trop Med Hyg 98:299–305PubMed el-Reshaid K, Varro J, al-Duwairi Q, Anim JT (1995) Takayasu’s arteritis in Kuwait. J Trop Med Hyg 98:299–305PubMed
7.
go back to reference el Asri A, Tazi-Mezalek Z, Aouni M, Adnaoui M, Mohattane A, Bensaid Y et al (2002) Takayasu’s disease in Morocco. Report of 47 cases. Rev Med Interne 23:9–20CrossRefPubMed el Asri A, Tazi-Mezalek Z, Aouni M, Adnaoui M, Mohattane A, Bensaid Y et al (2002) Takayasu’s disease in Morocco. Report of 47 cases. Rev Med Interne 23:9–20CrossRefPubMed
8.
go back to reference Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G et al (2005) Takayasu’s arteritis: A study of 104 Italian patients. Arthritis Rheum 53:100–107CrossRefPubMed Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G et al (2005) Takayasu’s arteritis: A study of 104 Italian patients. Arthritis Rheum 53:100–107CrossRefPubMed
9.
go back to reference Jain S, Sharma N, Singh S, Bali HK, Kumar L, Sharma BK (2000) Takayasu arteritis in children and young indians. Int J Cardiol 75(Suppl 1):S153–S157CrossRefPubMed Jain S, Sharma N, Singh S, Bali HK, Kumar L, Sharma BK (2000) Takayasu arteritis in children and young indians. Int J Cardiol 75(Suppl 1):S153–S157CrossRefPubMed
10.
go back to reference Ishikawa K (1978) Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation 57(1):27–35PubMed Ishikawa K (1978) Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation 57(1):27–35PubMed
11.
go back to reference Ishikawa K (1981) Survival and morbidity after diagnosis of occlusive thromboaortopathy (Takayasu’s disease). Am J Cardiol 47:1026–1032CrossRefPubMed Ishikawa K (1981) Survival and morbidity after diagnosis of occlusive thromboaortopathy (Takayasu’s disease). Am J Cardiol 47:1026–1032CrossRefPubMed
12.
go back to reference Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu’s disease). Circulation 80:429–437PubMed Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu’s disease). Circulation 80:429–437PubMed
13.
go back to reference Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F (1997) Clinical manifestations of Takayasu arteritis in India and Japan—new classification of angiographic findings. Angiology 48:369–379PubMed Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F (1997) Clinical manifestations of Takayasu arteritis in India and Japan—new classification of angiographic findings. Angiology 48:369–379PubMed
14.
go back to reference Ishikawa K, Maetani S (1994) Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors. Circulation 90:1855–1860PubMed Ishikawa K, Maetani S (1994) Long-term outcome for 120 Japanese patients with Takayasu’s disease. Clinical and statistical analyses of related prognostic factors. Circulation 90:1855–1860PubMed
15.
go back to reference Nishimoto N, Nakahara H, Yoshio-Hoshino N, Mima T (2008) Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum 58:1197–1200CrossRefPubMed Nishimoto N, Nakahara H, Yoshio-Hoshino N, Mima T (2008) Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum 58:1197–1200CrossRefPubMed
Metadata
Title
Clinical and radiological features of Takayasu’s arteritis patients in Jordan
Authors
Khader N. Mustafa
Azmy Hadidy
Nadera J. Sweiss
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1163-5

Other articles of this Issue 11/2010

Rheumatology International 11/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine